In a strategic move to enter the Over-the-Counter (OTC) market within the ophthalmology sector, Ildong Pharmaceutical has signed an eye drop co-promotion agreement with Hanlim Pharm. The collaboration marks a significant step for Ildong Pharmaceutical as it aims to expand its presence in the domestic pharmacy market.
The co-promotion will focus on three exclusive brands of over-the-counter eye drops – Nazorin, Numaren, and Eyefeel – all set to be distributed and sold exclusively by Ildong Pharmaceutical starting this month.
Nazorin Eye Drops, formulated with pheniramine maleate and naphazoline HCl, offer temporary relief from eye irritation and redness. These drops provide an effective, convenient solution for individuals experiencing ocular discomfort due to allergens, pollutants, or strain.
Numaren Eye Drops cater to individuals with dry eyes and insufficient tear production. The hypromellose-dextran formulation is available in two packaging options: single-dose and multi-dose. The preservative-free single-dose variant is particularly suitable for lens wearers, ensuring safety and comfort for sensitive eyes.
Eyefeel Eye Drops stand out as an innovative ophthalmic solution containing aminocaproic acid, neostigmine methylsulfate, naphazoline HCl, and chlorpheniramine maleate. This multifaceted formulation targets eye inflammation, fatigue, and redness, making it a versatile option for maintaining eye health in a variety of scenarios.
Kang Dae-seok, Head of CHC-CM Group at Ildong Pharmaceutical, expressed confidence in the collaboration, stating, "Based on our market research, we found that the number of consumers looking for ophthalmic solutions at pharmacies is steadily increasing due to the growing use of IT devices, including computers and smartphones. We will continue to promote the importance of eye health with our products."
This partnership ensures that Ildong Pharmaceutical will exclusively distribute and sell these eye drop brands, providing greater accessibility for consumers seeking quality ophthalmic solutions. With this collaboration, Ildong solidifies its position as a key player in the OTC ophthalmology market.